toyocamycin has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernier-Rodriguez, M; Drach, JC; Kern, ER; Krawczyk, SH; Nassiri, MR; Townsend, LB; Wotring, LL | 1 |
| Balzarini, J; De Clercq, E; Hansske, F; Madej, D; Robins, MJ | 1 |
2 other study(ies) available for toyocamycin and Leukemia L 1210
| Article | Year |
|---|---|
Arabinofuranosylpyrrolo[2,3-d]pyrimidines as potential agents for human cytomegalovirus infections.
Topics: Animals; Antiviral Agents; Arabinonucleosides; Cell Division; Chemical Phenomena; Chemistry; Cytomegalovirus; Cytomegalovirus Infections; Humans; Leukemia L1210; Mice; Molecular Structure; Pyrimidine Nucleosides; Simplexvirus; Structure-Activity Relationship; Toyocamycin; Tumor Cells, Cultured | 1990 |
Nucleic acid related compounds. 51. Synthesis and biological properties of sugar-modified analogues of the nucleoside antibiotics tubercidin, toyocamycin, sangivamycin, and formycin.
Topics: Animals; Antibiotics, Antineoplastic; Antiviral Agents; Formycins; Leukemia L1210; Mice; Microbial Sensitivity Tests; Pyrimidine Nucleosides; Ribonucleosides; Structure-Activity Relationship; Toyocamycin; Tubercidin | 1987 |